Atlas Trials

Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder

Clinical trial NCT07182409 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07182409
Sponsor
First Affiliated Hospital of Chongqing Medical University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
NMOSD
Start date
2025-10-01
Primary completion
2026-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.